If you made any changes in Pure, your changes will be visible here soon.

Research Output 1988 2018

Filter
Article
Article
72 Citations (Scopus)

Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy

Weiner, M., Bock, N., Peloquin, C. A., Burman, W. J., Khan, A., Vernon, A., Zhao, Z., Weis, S., Sterling, T. R., Hayden, K. & Goldberg, S., 1 Jun 2004, In : American Journal of Respiratory and Critical Care Medicine. 169, 11, p. 1191-1197 7 p.

Research output: Contribution to journalArticle

rifapentine
Tuberculosis
Pharmacokinetics
Therapeutics
Isoniazid
39 Citations (Scopus)

Prevalence of anal intraepithelial neoplasia defined by anal cytology screening and high-resolution anoscopy in a primary care population of HIV-infected men and women

Weis, S., Vecino, I., Pogoda, J. M., Susa, J. S., Nevoit, J., Radaford, D., McNeely, P., Colquitt, C. A. & Adams, E., 1 Apr 2011, In : Diseases of the Colon and Rectum. 54, 4, p. 433-441 9 p.

Research output: Contribution to journalArticle

Cell Biology
Primary Health Care
HIV
Population
Neoplasms
4692 Citations (Scopus)

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS

Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W. & Gotto, A. M., 27 May 1998, In : Journal of the American Medical Association. 279, 20, p. 1615-1622 8 p.

Research output: Contribution to journalArticle

Lovastatin
Primary Prevention
LDL Cholesterol
Cholesterol
Unstable Angina
58 Citations (Scopus)

Production of interleukin-18 in human tuberculosis

Vankayalapati, R., Wizel, B., Weis, S., Samten, B., Girard, W. M. & Barnes, P. F., 12 Aug 2000, In : Journal of Infectious Diseases. 182, 1, p. 234-239 6 p.

Research output: Contribution to journalArticle

Interleukin-18
Tuberculosis
Interferons
Mycobacterium tuberculosis
Blood Cells
94 Citations (Scopus)

Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-γ release assays in persons with suspected tuberculosis

Mazurek, G. H., Weis, S., Moonan, P. K., Daley, C. L., Bernardo, J., Lardizabal, A. A., Reves, R. R., Toney, S. R., Daniels, L. J. & LoBue, P. A., 22 Oct 2007, In : Clinical Infectious Diseases. 45, 7, p. 837-845 9 p.

Research output: Contribution to journalArticle

Tuberculin Test
Skin Tests
Interferons
Tuberculosis
Mycobacterium tuberculosis
106 Citations (Scopus)

Pulmonary impairment after tuberculosis

Pasipanodya, J. G., Miller, T. L., Vecino, M., Munguia, G., Garmon, R., Bae, S., Drewyer, G. & Weis, S., 1 Jan 2007, In : Chest. 131, 6, p. 1817-1824 8 p.

Research output: Contribution to journalArticle

Latent Tuberculosis
Tuberculosis
Lung
Pulmonary Tuberculosis
Vital Capacity
37 Citations (Scopus)

Pulmonary impairment after tuberculosis and its contribution to TB burden

Pasipanodya, J. G., McNabb, S. J., Hilsenrath, P., Bae, S., Lykens, K., Vecino, E., Munguia, G., Miller, T. L., Drewyer, G. & Weis, S., 21 May 2010, In : BMC Public Health. 10, 259.

Research output: Contribution to journalArticle

Tuberculosis
Lung
Quality-Adjusted Life Years
Life Tables
Health
61 Citations (Scopus)

Ransmission dynamics of tuberculosis in Tarrant County, Texas

Weis, S., Pogoda, J. M., Yang, Z., Donald Cave, M., Wallace, C., Kelley, M. & Barnes, P. F., 1 Jul 2002, In : American Journal of Respiratory and Critical Care Medicine. 166, 1, p. 36-42 7 p.

Research output: Contribution to journalArticle

Tuberculosis
Restriction Fragment Length Polymorphisms
Homeless Persons
Mycobacterium tuberculosis
Cluster Analysis

Recurrent Granuloma Gluteale Infantum Secondary to Fecal Overflow Incontinence

Ingersoll, Z., Garza-Chapa, J. I., Pham, R., Malouf, P., Susa, J. & Weis, S., 1 May 2018, In : Case Reports in Dermatology. 10, 2, p. 203-207 5 p.

Research output: Contribution to journalArticle

Fecal Incontinence
Granuloma
Irritant Dermatitis
Contact Dermatitis
Recurrence
22 Citations (Scopus)

Reduced expression of nuclear cyclic adenosine 5′-monophospate response element-binding proteins and IFN-γ promoter function in disease due to an intracellular pathogen

Samten, B., Ghosh, P., Yi, A. K., Weis, S., Lakey, D. L., Gonsky, R., Pendurthi, U., Wizel, B., Zhang, Y., Zhang, M., Gong, J., Fernandez, M., Safi, H., Vankayalapati, R., Young, H. A. & Barnes, P. F., 1 Apr 2002, In : Journal of Immunology. 168, 7, p. 3520-3526 7 p.

Research output: Contribution to journalArticle

Response Elements
Adenosine
Carrier Proteins
Tuberculosis
Cyclic AMP Response Element-Binding Protein
482 Citations (Scopus)

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

Gotto, A. M., Whitney, E., Stein, E. A., Shapiro, D. R., Clearfield, M., Weis, S., Jou, J. Y., Langendörfer, A., Beere, P. A., Watson, D. J., Downs, J. R. & De Cani, J. S., 8 Feb 2000, In : Circulation. 101, 5, p. 477-484 8 p.

Research output: Contribution to journalArticle

LDL Cholesterol
Apolipoproteins B
Coronary Artery Disease
Air
Lipids
334 Citations (Scopus)

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: A randomised clinical trial

Benator, D., Bhattacharya, M., Bozeman, L., Burman, W., Catanzaro, A., Chaisson, R., Gordin, F., Horsburgh, C. R., Horton, J., Khan, A., Lahart, C., Metchock, B., Pachucki, C., Stanton, L., Vernon, A., Villarino, M. E., Yong, C. W., Weiner, M., Weis, S., Horsburgh, C. R. & 1 others, Burman, W., 17 Aug 2002, In : Lancet. 360, 9332, p. 528-534 7 p.

Research output: Contribution to journalArticle

rifapentine
Isoniazid
Rifampin
Pulmonary Tuberculosis
Randomized Controlled Trials
HIV
CD4 Lymphocyte Count
Therapeutics
RNA
Randomized Controlled Trials
55 Citations (Scopus)

Serum cytokine concentrations do not parallel Mycobacterium tuberculosis - Induced cytokine production in patients with tuberculosis

Vankayalapati, R., Wizel, B., Weis, S., Klucar, P., Shams, H., Samten, B. & Barnes, P. F., 1 Jan 2003, In : Clinical Infectious Diseases. 36, 1, p. 24-28 5 p.

Research output: Contribution to journalArticle

Mycobacterium tuberculosis
Interleukin-10
Interferons
Tuberculosis
Interleukin-18
207 Citations (Scopus)

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis

Dorman, S. E., Johnson, J. L., Goldberg, S., Muzanye, G., Padayatchi, N., Bozeman, L., Heilig, C. M., Bernardo, J., Choudhri, S., Grosset, J. H., Guy, E., Guyadeen, P., Leus, M. C., Maltas, G., Menzies, D., Nuermberger, E. L., Villarino, M., Vernon, A., Chaisson, R. E., Mugerwa, R. D. & 148 others, Mayanja-Kizza, H., Gitta, P., Okwera, A., Lamunu, D., Nsubuga, P., Joloba, M., Morgan, K., Mulumba, Y., Nakibali, J. G., Kimera, J., Ssaku, E., El-Sadr, W., Bamber, S., Christop Chinappa, S. T., Hirsch-Moverman, Y., Naidoo, V., Mnguni, N., Mthethwa, T., Gumede, Z., Ganas, K., Conde, M. B., Efron, A., Loredo, C., Marsico, A. G., Vieira, G. B. D. O., Weis, S., King, B., Turk, L., Stevenson, G., Helal, J., Shafer, N., Dunbar, D., Hamill, R., Scott, T., Nickson, R., Goodrich, K., Cayla, J. A., Miró, J. M., Sanchez, F., Moreno, A., Martinez, J. A., Sambeat, M. A., López Colomés, J. L., De Souza, M. L., Jiménez, M. A., Milà, C., Lacasa, X. M., Coll, P., Cuchi, E., Gonzalez, J., Martin, N., Salvado, M., Weiner, M. H., Wing, R., Wing, D., Uribe, J., Engle, M., Calderin, A., Catanzaro, A., Moser, K. S., Tracy, M. J., Francisco, V. P., Davis, J., Reed, S., Peter, C. R., Jones, B. E., Rayos, E., Brown, M., Oamar, B. P., Sum, S., Reves, R., Burman, W., Tapy, J., Belknap, R., Sanchez, G., Hildred, G., Pachucki, C., Marantz, S., Lee, A., Samuel, M. P., Kubba, S., Mangura, B. T., Reichman, L. B., Owens, M., Napolitano, E., Burday, M., Sickles, D., Ray, S. M., Holland, D. P., Dixon, D., Mohamed, O., Folami, K., Bush, J., Duran, P., Sadkowski, L. C., Dorman, S., Fisher, J., Hooper, N., Kepron, W., Roth, M., Hoban, D., Saukkonen, J., Horsburgh, C. R., Murphy, C., Brett-Curran, D., Westerling, J., Schluger, N. W., Burzynski, J., Lozano, V., Wolk, M., Ebrahimzadeh, A., Hamilton, C. D., Stout, J., Mosher, A., Hecker, E., Bargothi, S., Bhattacharya, M., Lippold, S., Clapp, W., Fabre, J., Narwocki, J., Klein, M., Tankoano, Y., Badshah, C., Schichi, J., Al-Nasir, M., Razeq, J. H., Narita, M., Schwartz, D., Pass, J., Nahid, P., Hopewell, P., Merri-field, C., Rudoy, I., Israel, J., Babst, A., Sterling, T. R., Kerrigan, A., Smith, T., Gordin, F. M., Benator, D., Conwell, D. S., Schwartzman, K., Greenaway, C., Pelletier, M., Valiquette, C., Plaisir, P. & Thibert, L., 1 Aug 2009, In : American Journal of Respiratory and Critical Care Medicine. 180, 3, p. 273-280 8 p.

Research output: Contribution to journalArticle

Isoniazid
Pulmonary Tuberculosis
Sputum
Therapeutics
Arm
515 Citations (Scopus)

The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis

Weis, S., Slocum, P. C., Blais, F. X., King, B., Nunn, M., Matney, G. B., Gomez, E. & Foresman, B. H., 28 Apr 1994, In : New England Journal of Medicine. 330, 17, p. 1179-1184 6 p.

Research output: Contribution to journalArticle

Directly Observed Therapy
Drug Resistance
Tuberculosis
Recurrence
Observation
68 Citations (Scopus)

The effects of local review on informed consent documents from a multicenter clinical trials consortium

Burman, W., Breese, P., Weis, S., Bock, N., Bernardo, J. & Vernon, A., 1 Jan 2003, In : Controlled Clinical Trials. 24, 3, p. 245-255 11 p.

Research output: Contribution to journalArticle

Consent Forms
Multicenter Studies
Clinical Trials
Research Ethics Committees
Reading
4 Citations (Scopus)

The efficacy of gemfibrozil therapy for raising high density lipoprotein levels

Weis, S., Kudchodkar, B. J., Clearfield, M. B. & Lacko, A. G., 1 Jan 1992, In : Artery. 19, 6, p. 353-367 15 p.

Research output: Contribution to journalArticle

Gemfibrozil
HDL Lipoproteins
HDL Cholesterol
Serum
Body Weight Changes
108 Citations (Scopus)

The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium

Vankayalapati, R., Wizel, B., Weis, S., Safi, H., Lakey, D. L., Mandelboim, O., Samten, B., Porgador, A. & Barnes, P. F., 1 Apr 2002, In : Journal of Immunology. 168, 7, p. 3451-3457 7 p.

Research output: Contribution to journalArticle

Natural Cytotoxicity Triggering Receptor 1
Phagocytes
Natural Killer Cells
Monocytes
Bacteria
17 Citations (Scopus)

The Societal Cost of Tuberculosis: Tarrant County, Texas, 2002

Miller, T. L., McNabb, S. J. N., Hilsenrath, P., Pasipanodya, J., Drewyer, G. & Weis, S., 1 Jan 2010, In : Annals of Epidemiology. 20, 1, p. 1-7 7 p.

Research output: Contribution to journalArticle

Tuberculosis
Costs and Cost Analysis
Infection
Latent Tuberculosis
Cost of Illness
422 Citations (Scopus)

Three months of rifapentine and isoniazid for latent tuberculosis infection

Sterling, T. R., Villarino, M. E., Borisov, A. S., Shang, N., Gordin, F., Bliven-Sizemore, E., Hackman, J., Hamilton, C. D., Menzies, D., Kerrigan, A., Weis, S., Weiner, M., Wing, D., Conde, M. B., Bozeman, L., Horsburgh, C. R. & Chaisson, R. E., 8 Dec 2011, In : New England Journal of Medicine. 365, 23, p. 2155-2166 12 p.

Research output: Contribution to journalArticle

rifapentine
Latent Tuberculosis
Isoniazid
Group Psychotherapy
Tuberculosis
32 Citations (Scopus)

Transmission of drug-resistant tuberculosis in Texas and Mexico

Quitugua, T. N., Seaworth, B. J., Weis, S., Taylor, J. P., Gillette, J. S., Rosas, I. I., Jost, K. C., Magee, D. M. & Cox, R. A., 1 Aug 2002, In : Journal of Clinical Microbiology. 40, 8, p. 2716-2724 9 p.

Research output: Contribution to journalArticle

Multidrug-Resistant Tuberculosis
Mexico
Pharmaceutical Preparations
Genotype
Cluster Analysis
26 Citations (Scopus)

Treatment costs of directly observed therapy and traditional therapy for Mycobacterium tuberculosis: A comparative analysis

Weis, S., Foresman, B., Matty, K. J., Brown, A., Blais, F. X., Burgess, G., King, B., Cook, P. E. & Slocum, P. C., 1 Nov 1999, In : International Journal of Tuberculosis and Lung Disease. 3, 11, p. 976-984 9 p.

Research output: Contribution to journalArticle

Directly Observed Therapy
Mycobacterium tuberculosis
Health Care Costs
Costs and Cost Analysis
Tuberculosis
73 Citations (Scopus)

Treatment for preventing tuberculosis in children and adolescents: A randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and Isoniazid

International Maternal Pediatric and Adolescents AIDS Clinical Trials Group (IMPAACT) and the Tuberculosis Trials Consortium (TBTC), 1 Mar 2015, In : JAMA Pediatrics. 169, 3, p. 247-255 9 p.

Research output: Contribution to journalArticle

rifapentine
Isoniazid
Tuberculosis
Randomized Controlled Trials
Latent Tuberculosis
28 Citations (Scopus)

Treatment of high-grade anal intraepithelial neoplasia with infrared coagulation in a primary care population of HIV-infected men and women

Weis, S., Vecino, I., Pogoda, J. M. & Susa, J. S., 1 Dec 2012, In : Diseases of the Colon and Rectum. 55, 12, p. 1236-1243 8 p.

Research output: Contribution to journalArticle

Primary Health Care
HIV
Population
Neoplasms
Squamous Cell Carcinoma
7 Citations (Scopus)

Tuberculosis: What is the yield of associate investigations in non-BCG-immunized children with positive tuberculin skin tests?

Moonan, P. K., Marruffo, M., Manguia-Bayona, G., Sahbazian, B., Bayona, M., Burgess, G. & Weis, S., 1 Mar 2005, In : International Journal of Tuberculosis and Lung Disease. 9, 3, p. 322-327 6 p.

Research output: Contribution to journalArticle

Tuberculin Test
Skin Tests
Tuberculosis
Urban Health
42 Citations (Scopus)

Tuberculosis in the foreign-born population of Tarrant County, Texas by immigration status

Weis, S., Moonan, P. K., Pogoda, J. M., Turk, L., King, B., Freeman-Thompson, S. & Burgess, G., 15 Sep 2001, In : American Journal of Respiratory and Critical Care Medicine. 164, 6, p. 953-957 5 p.

Research output: Contribution to journalArticle

Emigration and Immigration
Tuberculosis
Population
Hospitalization
HIV
12 Citations (Scopus)

Underuse of effective measures to prevent and manage pediatric tuberculosis in the United States

Lobato, M. N., Sun, S. J., Moonan, P. K., Weis, S., Saiman, L., Reichard, A. A. & Feja, K., 1 May 2008, In : Archives of Pediatrics and Adolescent Medicine. 162, 5, p. 426-431 6 p.

Research output: Contribution to journalArticle

Tuberculosis
Pediatrics
Latent Tuberculosis
Public Health
Infection
19 Citations (Scopus)

Universal directly observed therapy: A treatment strategy for tuberculosis

Weis, S., 1 Jan 1997, In : Clinics in Chest Medicine. 18, 1, p. 155-163 9 p.

Research output: Contribution to journalArticle

Directly Observed Therapy
Tuberculosis
Therapeutics
Patient Compliance
Patient Selection
8 Citations (Scopus)

Universal HIV screening at a major metropolitan TB clinic: HIV prevalence and high-risk behaviors among TB patients

Weis, S., Foresman, B., Cook, P. E. & Matty, K. J., 1 Jan 1999, In : American journal of public health. 89, 1, p. 73-75 3 p.

Research output: Contribution to journalArticle

Risk-Taking
Tuberculosis
HIV
HIV Antibodies
HIV Infections
16 Citations (Scopus)

Using cost and health impacts to prioritize the targeted testing of tuberculosis in the United States

Miller, T. L., Hilsenrath, P., Lykens, K., Mcnabb, S. J. N., Moonan, P. K. & Weis, S., 1 Apr 2006, In : Annals of Epidemiology. 16, 4, p. 305-312 8 p.

Research output: Contribution to journalArticle

Health Care Costs
Tuberculosis
Infection
Latent Tuberculosis
Homeless Persons
60 Citations (Scopus)

Using GIS technology to identify areas of tuberculosis transmission and incidence

Moonan, P. K., Bayona, M., Quitugua, T. N., Oppong, J., Dunbar, D., Jost, K. C., Burgess, G., Singh, K. P. & Weis, S., 13 Oct 2004, In : International Journal of Health Geographics. 3, 23.

Research output: Contribution to journalArticle

Geographic Information Systems
Geographic information systems
Tuberculosis
Technology
Screening
48 Citations (Scopus)

Using the St. George Respiratory Questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis

Pasipanodya, J. G., Miller, T. L., Vecino, M., Munguia, G., Bae, S., Drewyer, G. & Weis, S., 1 Jan 2007, In : Chest. 132, 5, p. 1591-1598 8 p.

Research output: Contribution to journalArticle

Pulmonary Tuberculosis
Latent Tuberculosis
Health
Tuberculosis
Quality of Life
5 Citations (Scopus)

What Are the Costs of Suspected But Not Reported Tuberculosis?

Miller, T. L., Reading, J. A., Hilsenrath, P. & Weis, S., 1 Oct 2006, In : Annals of Epidemiology. 16, 10, p. 777-781 5 p.

Research output: Contribution to journalArticle

Tuberculosis
Costs and Cost Analysis
Bacillus
Acids
Mycobacterium
31 Citations (Scopus)

What is the outcome of targeted tuberculosis screening based on universal genotyping and location?

Moonan, P. K., Oppong, J., Sahbazian, B., Singh, K. P., Sandhu, R., Drewyer, G., LaFon, T., Marruffo, M., Quitugua, T. N., Wallace, C. & Weis, S., 1 Sep 2006, In : American Journal of Respiratory and Critical Care Medicine. 174, 5, p. 599-604 6 p.

Research output: Contribution to journalArticle

Tuberculosis
Latent Tuberculosis
Geographic Information Systems
Systems Analysis
Mycobacterium tuberculosis